title: A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
abstract: Allergic Bronchopulmonary Mycosis (ABPM) is an exagregated immunologic response to fungal colonization in the lower airways. It may cause by many kinds of fungal, but Aspergillus fumigatus is the most common cause of ABPM, although other Aspergillus and other fungal organisms, like Candida albicans, have been implicated. Aspergllus fumigatus and Candida albicans may be found as outdoor and indoor fungi, and cause the sensitization, elicitation of the disease pathology, and its clinical manifestations. Several diagnostic procedurs may be impicated to support the diagnosis of ABPM caused by Aspergillus fumigatus and Candida albicans. A case of allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans in a 48 year old man was discussed. The patient was treated with antifungal, corticosteroids, and antibiotic for the secondary bacterial infection. The patient's condition is improved without any significant side effects.
authors: Department of Internal Medicine, Siloam International Hospitals (SHPM). Siloam Hospitals Group's CEO Office. Siloam Hospital Lippo Village 5th floor, Jl. Siloam No.6, Karawaci, Indonesia. wadiswas@yahoo.com
authors: Wardhana
authors: E A
authors: EA
authors: Datau
mesh_terms: D000551:Ambroxol / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D019819:Budesonide / Q000627:therapeutic use; D002176:Candida albicans / Q000302:isolation & purification*; D002177:Candidiasis / Q000175:diagnosis; D004983:Ethanolamines / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D015725:Fluconazole / Q000627:therapeutic use; D000068759:Formoterol Fumarate; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D055744:Invasive Pulmonary Aspergillosis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D017964:Itraconazole / Q000627:therapeutic use; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D001993:Bronchodilator Agents; D004983:Ethanolamines; D005100:Expectorants; D005938:Glucocorticoids; D000551:Ambroxol; D017964:Itraconazole; D019819:Budesonide; D015725:Fluconazole; D015242:Ofloxacin; D000068759:Formoterol Fumarate; D008775:Methylprednisolone